The insurer Zurich Switzerland, a Swiss subsidiary of the Zurich Insurance group, has acquired a 25% stake in the share capital of Brokerbusiness.ch., an insurtech start-up that operates a digital insurtech platform with an innovative consulting, tender and comparison software for brokers. The financial terms of the transaction were not disclosed. Advestra advises Zurich Insurance on its […]
Baker McKenzie advised Amsterdam-based Keesing Media Group (Keesing) on the acquisition of the Swiss Küng Group. The deal will enable Keesing to to strengthen its European market presence and develop a stronger foothold in
The Deutsche Börse Group, an international exchange organisation and innovative market infrastructure provider, acquires a majority of the shares in Crypto Finance, a Swiss crypto broker and asset manager. Through the acquisition, Deutsche Bö
EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
Norres, a portfolio company of Triton Smaller Mid-Cap Fund I, acquired the Baggerman Group. The parties have agreed not to disclose the purchase price. The Baggerman Group, headquartered in Roermond, Netherlands, is a specialist
The city of Sierre, the association of the municipalities of the District of Sierre and TechnoArk acquired a majority stake in the Techno-Pôle of Sierre. Python acted as counsel to the buyers. Python team
Maus Frères and Coop-Group cooperative announced the sale of all shares of Jumbo-Markt, a Swiss do-it-yourself store operator, for an undisclosed consideration. Following merger control clearance by the Swiss Competition Commission the transaction has
Combioxin, a clinical phase biotechnology company based in Epalinges, Switzerland, has signed a worldwide commercial license agreement with Eagle Pharmaceuticals, a fully integrated pharmaceutical company based in Woodcliff Lake, NY, USA. Under the terms of
La Mobilière, TX Group, Ringier and General Atlantic form a joint venture to create a digital marketplace group. The CEO of the joint venture will be Gilles Despas, currently CEO of the Scout24 Switzerland
VectivBio Holding, clinical-stage biopharmaceutical company specialising in novel transformational treatments for severe rare conditions announced the acquisition of Comet Therapeutics, a biotechnology company that has been developing drugs to address previously untreatable inherited metabolic diseases.
